Text and Data Mining valid from 2017-11-27
Received: 12 May 2016
Accepted: 31 October 2017
First Online: 27 November 2017
Change Date: 1 January 2018
Change Type: Corrigendum
Change Details: In the version of this article initially published online, a micrograph in Figure 1d (WT, Vehicle) and a micrograph in Figure 2a (<i>Gsdmd</i><sup><i>−/−</i></sup>, <i>Alu</i> RNA) are duplicates of two other micrographs and are incorrect. These errors do not affect the quantitative data reported or the conclusions of the article. These two micrographs have been replaced with the correct ones in the print, PDF and HTML versions of this article.
: J.A. is a cofounder of iVeena Holdings, iVeena Pharmaceuticals, iVeena Delivery Systems, and Inflammasome Therapeutics, and has been a consultant for Allergan, Biogen, and Olix Pharmaceuticals in a capacity unrelated to this work. J.A., N.K., B.J.F., and K.A. are named as inventors on patent applications on macular degeneration filed by the University of Kentucky or the University of Virginia.